The global multiplex assays market is expected to reach $6.24 billion by 2030, driven by the preference for multiplex assays over singleplex varieties and…
Browsing: Autoimmune Diseases
Seismic Therapeutic, Inc. will be presenting data on their novel therapeutics for autoimmune diseases and their IMPACT platform that utilizes machine learning for drug…
Seismic Therapeutics, Inc. is a machine learning immunology company that applies its proprietary IMPACT platform to discover novel therapeutics for autoimmune diseases. They will…